Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback